NEW YORK, May 2, 2011 /PRNewswire/ — Lpath, Inc. (OTCBB: LPTN),
the category leader in bioactive-lipid-targeted
therapeutics, today announced that Scott Pancoast, Lpath
President and CEO, will present at
May 5th, 2011TIME:
3:00 PM EDTLINK:
the red “register/ watch event now” button.This will be a live,
interactive online event where investors are invited to ask the
company questions in real-time both in the presentation hall as
well as the company’s “virtual trade booth.” If attendees are not
able to join the event live in real-time, an on-demand archive will
be available for 90 days.
It is recommended that investors pre-register to save time and
receive event updates.
About LpathSan Diego-based Lpath, a therapeutic antibody
company, is the category leader in lipidomics-based therapeutics,
an emerging field of medicine that targets bioactive signaling
lipids for treating a wide range of human disease. Lpath’s
ImmuneY2(TM) drug-discovery engine has the unique ability to
generate therapeutic antibodies that bind to and inhibit bioactive
lipids that contribute to disease. The company has developed three
drug candidates, two of which — ASONEP(TM) for cancer and
iSONEP(TM) for wet AMD — have completed Phase 1 clinical trials.
Lpath entered into an agreement with Pfizer in 2010 that provides
Pfizer an exclusive option for a worldwide license to develop and
commercialize iSONEP. For more information, visit www.Lpath.com.
created by BetterInvesting
Newswire and MUNCmedia, is the first monthly virtual
investor conference series that provides an interactive f